drugset / Trial / NCT02060487
Effects of Oral Sildenafil on Mortality in Adults With PAH
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day \[TID\]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.
Timeline
- Start
- 2014-09-22
- Primary completion
- 2021-02-26
- Completion
- 2021-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 5 mg | Oral |
| Subject | Sildenafil | Unknown | 20 mg | Oral |
| Subject | Sildenafil | Unknown | 80 mg | Oral |